Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Roche Holding AG Basel American Depositary Shares (OP: RHHBY)
43.81 USD  -0.07 (-0.17%)
Streaming Delayed Price  /  Updated: 11:07 AM EDT, Jul 7, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 162,310
Open 43.63
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 43.88
Today's Range 43.59 - 43.89
52wk Range 25.10 - 46.00
Shares Outstanding 6,830,797,784
Dividend Yield 2.10%
Performance
YTD
+7.14%
+7.14%
1 Month
+2.19%
+2.19%
3 Month
+5.19%
+5.19%
6 Month
+6.80%
+6.80%
1 Year
+26.25%
+26.25%
Top News
More News
Cancer Immunotherapy Gets Boost from Newly Engineered Nanoparticles
category Featured News
from FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Cancer Immunotherapy Gets Boost from Newly Engineered Nanoparticles
FN Media Group Presents USA News Group News Commentary Read More
from PR Newswire
More News
Read More
Roche receives FDA approval for cobas EZH2 Mutation Test as a companion diagnostic for patients with follicular lymphoma
from PR Newswire
FDA Approves Genentech’s Phesgo (Fixed-dose Combination of Perjeta and Herceptin for Subcutaneous Injection) for HER2-positive Breast Cancer
from Business Wire News Releases
Genentech’s IPATential150 Study Evaluating Ipatasertib in Combination With Abiraterone and Prednisone/Prednisolone Met One of Its Co-Primary Endpoints
from Business Wire News Releases
Genentech’s Tecentriq in Combination With Chemotherapy (including Abraxane) Meets Primary Endpoint of Improved Pathological Complete Response, Regardless of PD-L1 Status, as Initial Treatment for Peop
from Business Wire News Releases
SpeeDx and Roche Partner to Expand Access to Antibiotic Resistance Tests
from Business Wire News Releases
How gene therapy and CRISPR are helping to cure blindness
category CH:NOVN , RHHBY , Opinion , and 9 more.
from MarketWatch
Positive Phase III Results for Venclexta Combination in Acute Myeloid Leukemia Presented At EHA 2020
from Business Wire News Releases
Genentech Announces 2-Year Risdiplam Data From SUNFISH and New Data From JEWELFISH in Infants, Children and Adults With Spinal Muscular Atrophy (SMA)
from Business Wire News Releases
Gilead Unveils New Wave Of Coronavirus Tests, Including Inhaled Drug
from Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.